In our upcoming issue of Nordic Life Science, Thomas Lönngren, former head of the EMA, emphasizes five important hurdles to identify for the pharmaceutical sector.
Thomas Lönngren’s years from the regulatory side and the last ten years as a consultant have provided him with a proper global overview of what the pharmaceutical sector is facing. In general, the industry, including small to large companies, is dealing with same kind of obstacles, he says. According to Lönngren, there are five important hurdles to identify. Read more about these in our upcoming issue, out September 9th.
Lönngren also gives us his view on Brexit and its consequences.